Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters

Psychopharmacology

Volumn 217, Issue 2, 2011, Pages 289-295

  Haenisch, Britta ^a   Hiemke, Christoph ^b   Bönisch, Heinz ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

2 Hydroxy trimipramine; Desmethyl trimipramine; Dopamine transporter; MPP +; Noradrenaline transporter; Organic cation transporter; Serotonin transporter; Trimipramine; Trimipramine metabolites; Trimipramine N oxide

Indexed keywords

2 HYDROXYTRIMIPRAMINE; ANTIDEPRESSANT AGENT; MONOAMINE; NORADRENALIN TRANSPORTER; NORTRIMIPRAMINE; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; SEROTONIN TRANSPORTER; TRIMIPRAMINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; STEADY STATE;

ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; CELL CULTURE TECHNIQUES; DATA INTERPRETATION, STATISTICAL; HEK293 CELLS; HUMANS; MOLECULAR STRUCTURE; NEUROTRANSMITTER TRANSPORT PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; REGRESSION ANALYSIS; TRANSFECTION; TRIMIPRAMINE;

EID: 82955198423     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2281-9     Document Type: Article

References (33)

1. Amphoux A, Vialou V, Drescher E, Brüss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bönisch H, Gautron S (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941-952 (Pubitemid 43810126)
2. Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A 105:18976-18981
3. Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:243-265 (Pubitemid 39587052)
4. Busch AE, Quester S, Ulzheimer JC, Gorboulev V, Akhoundova A, Waldegger S, Lang F, Koepsell H (1996) Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395:153-156 (Pubitemid 26356174)
5. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
6. Eap CB, Bender S, Gastpar M, Fischer W, Haarmann C, Powell K, Jonzier-Perey M, Cochard N, Baumann P (2000) Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients. Ther Drug Monit 22:209-214 (Pubitemid 30196827)
7. Eikmeier G, Muszynski K, Berger M, Gastpar M (1990) High-dose trimipramine in acute schizophrenia. Preliminary results of an open trial. Pharmacopsychiatry 23:212-214 (Pubitemid 20354025)
8. Eikmeier G, Berger M, Lodemann E, Muszynski K, Kaumeier S, Gastpar M (1991) Trimipramine-an atypical neuroleptic? Int Clin Psychopharmacol 6:147-153
9. Feng N, Mo B, Johnson PL, Orchinik M, Lowry CA, Renner KJ (2005) Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 1063:69-76 (Pubitemid 41628209)
10. Glotzbach KR, Preskorn S (1982) Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology 78:25-27 (Pubitemid 12036015)
11. Gross G, Xin X, Gastpar M (1991) Trimipramine: pharmacological reevaluation and comparison with clozapine. Neuropharmacology 30:1159-1166
12. Gründemann D, Schechinger B, Rappold GA, Schömig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349-351
13. Haenisch B, Bönisch H (2010) Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Naunyn Schmiedebergs Arch Pharmacol 381:33-39
14. Hauser K, Olpe HR, Jones RS (1985) Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system. Eur J Pharmacol 111:23-30 (Pubitemid 15097837)
15. Hiemke C, Baumann P, Laux G, Kuss HJ (2005) Therapeutisches Drug-Monitoring in der Psychiatrie. Konsensus-Leitlinie der AGNP. Psychopharmakotherapie 12:166-182 (Pubitemid 41558514)
16. Kirchheiner J, Müller G, Meineke I, Wernecke KD, Roots I, Brockmöller J (2003a) Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics. J Clin Psychopharmacol 23:459-466 (Pubitemid 37128673)
17. Kirchheiner J, Sasse J, Meineke I, Roots I, Brockmöller J (2003b) Trimipramine pharmacokinetics after intravenous and oral administration in carriers of CYP2D6 genotypes predicting poor, extensive and ultrahigh activity. Pharmacogenetics 13:721-728 (Pubitemid 38429250)
18. Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227-1251 (Pubitemid 46876495)
19. Kopanski C, Türck M, Schultz JE (1983) Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex: Structure activity study. Neurochem Int 5:649-659 (Pubitemid 13019831)
20. Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A (2009) Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol - a double-blind multicenter trial. J Psychiatr Res 43:702-710
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
22. Maurer H (1989) Metabolism of trimipramine in man. Arzneimittelforschung 39:101-103 (Pubitemid 19030795)
23. Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology (Berl) 53:309-314 (Pubitemid 8140313)
24. Richelson E, Nelson A (1984) Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 230:94-102 (Pubitemid 14097664)
25. Schmitt A, Mössner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch KP (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71:701-709 (Pubitemid 36255354)
26. Seeman P (1992) Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261-284
27. Steiger A, Von Bardeleben U, Guldner J, Lauer C, Rothe B, Holsboer F (1993) The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS-active drugs. Prog Neuropsychopharmacol Biol Psychiatry 17:125-137
28. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258 (Pubitemid 28022649)
29. Weigmann H, Härtter S, Bagli M, Hiemke C (2000) Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain after oral administration of clomipramine. Eur Neuropsychopharmacol 10:401-405
30. Wenge B, Bönisch H (2009) Interference of the noradrenergic neurotoxin DSP4 with neuronal and nonneuronal monoamine transporters. Naunyn Schmiedebergs Arch Pharmacol 380:523-529
31. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786 (Pubitemid 28557664)
32. Wultsch T, Grimberg G, Schmitt A, Painsipp E, Wetzstein H, Breitenkamp AF, Gründemann D, Schömig E, Lesch KP, Gerlach M, Reif A (2009) Decreased anxiety in mice lacking the organic cation transporter 3. J Neural Transm 116:689-697
33. Yu PH, Boulton AA (1990) Effect of trimipramine, an atypical tricyclic antidepressant, on the activities of various enzymes involved in the metabolism of biogenic amines. Prog Neuropsychopharmacol Biol Psychiatry 14:409-416 (Pubitemid 20191904)